Today, SkylineDx announced a research collaboration with an academic hospital and a Dutch cancer registry to investigate patients with early-stage melanoma (skin cancer) at high risk of disease-related fatality.
Archive | Of Interest
Dutch consortium investigates biomarker to identify early-stage melanoma at high-risk of recurrence
Posted in Melanoma News, Health Professionals, Of Interest
Circulating tumor DNA could help guide treatment of BRAF V600-mutant metastatic melanoma
Circulating tumor DNA measurements before and during treatment could help guide selection of therapy for patients with BRAF V600-mutant unresectable or metastatic melanoma, according to study results published in The Lancet Oncology.
Posted in Melanoma News, Health Professionals, Of Interest
Gene-Based Blood Test for Melanoma Spread Evaluates Treatment Progress
A test that monitors blood levels of DNA fragments released by dying tumor cells may serve as an accurate early indicator of treatment success in the late stages of one of the most aggressive forms of skin cancer, a new study finds.
Posted in Melanoma News, Health Professionals, Of Interest
Dermoscopy helps differentiate benign melanocytic lesions vs. melanoma
Dermoscopy allows for thorough observation of morphologic features not visible to the naked eye in melanoma screening, according to a speaker at the South Beach Symposium Medical Dermatology Summit.
Posted in Melanoma News, Health Professionals, Of Interest
